CONTACT CSU

No offerings have been identified for this subject in 2015

DOH213 Oral Health Pathophysiology and Pharmacology 2 (12)

Abstract

This subject is a continuation of DOH212 Oral Health Physiology and Pharmacology 1. The subject explores pathophysiological processes contributing to systemic disease and continues the study of oral diseases. The systemic disease component of the subject focuses on pathophysiological processes associated with the nervous, endocrine, digestive, urinary and reproductive systems. Study of the immune system and healing is also incorprated in this subject. Pharmacology relevant to the management of diseases and topics covered is integrated throughout. Students will complete this subject with an understanding of diseases of these systems, of the oral implications of disease in these systems and of oral diseases including neoplasia, bone disease and salivary gland disorders as well as healing in the context of oral health practice.

+ Subject Availability Modes and Location

Continuing students should consult the SAL for current offering details prior to contacting their course coordinator: DOH213
Where differences exist between the handbook and the SAL, the SAL should be taken as containing the correct subject offering details.

Subject information

Duration Grading System School:
One sessionHD/FLSchool of Dentistry and Health Sciences

Enrolment restrictions

Restricted to students enrolled in the Bachelor of Oral Health (Therapy/Hygiene) course.
Prerequisite(s)Incompatible subject(s)Related subject(s)
DOH211 and DOH212BMS292 BMS292 BMS292 content is embedded into DOH213

Learning Outcomes

Upon successful completion of this subject, students should:
be able to:
* describe the pathogenesis of major central and peripheral nervous system dysfunction;
* outline the primary pharmacological interventions used in the treatment of central and peripheral nervous system dysfunction;
* discuss infections of the nervous system;
* describe the pathogenesis of the hypothalamic-pituitary system dysfunction;
* describe the pathogenesis of thyroid, endocrine, pancreas and adrenal gland dysfunction and outline the use of pharmacological agents in the treatment and management of hormonal dysfunction;
* describe the pathogenesis of disorders of the gastrointestinal system and accessory glands and their pharmacological treatment;
* name and describe the common disorders of the urinary system;
* describe the different types of renal failure;
* distinguish between obstructive, infective and glomerular disorders of the renal system;
* explain the use of pharmacological agents in the treatment and management of renal and urinary tract dysfunction;
* describe the common structural and functional alterations of the male and female reproductive system, including cancer and sexually transmitted infections;
* explain the use of pharmacological agents in the treatment and management of reproductive system dysfunction;
* explain the common causes of infertility and explain the pharmacological management of infertility;
* discuss the disorders and infections of the integument;
* discuss the mechanisms of wound healing and be able to apply this knowledge to the healing of oral soft and hard tissues;
* define immunity and differentiate between natural and acquired, and between primary and secondary immune responses;
* discuss cellular and humoral defence mechanisms;
* discuss the different types of hypersensitivity reactions;
* discuss congenital and acquired immunodeficiencies;
* describe and discuss the common benign and malignant tumours of oral soft tissues;
* describe and discuss the important primary and secondary forms of pathology of the salivary glands and their clinical consequences;
* describe the common forms of focal bone disease involving the jaws.

Syllabus

The subject will cover the following topics:
* Nervous dysfunction (coma, epilepsy, cerebrovascular acident, dementia, multiple sclerosis, glaucoma) and associated pharmacology * Endocrine dysfunction (hyperthyroidism, hypothyroidism, diabetes mellitus) and associated pharmacology * Digestive dysfunction (gastrointestinal ulceration, hepatitis, liver failure, cholelithiasis, cholecystitis, pancreatitis) and associated pharmacology * Urinary dysfunction (renal lithiasis, glomerular disorders, renal failure) and associated pharmacology * Integumentary dysfunction (including wounds) and associated pharmacology * Reproductive dysfunction (infertility) and associated pharmacology * Immune function (natural and acquired immunity, primary and secondary immune responses, humoral immune response, cell-mediated immune response), dysfunction (hypersensitivity, allergy, immunodeficiency (congenital and acquired), autoimmunity, alloimmunity) and associated pharmacology * Oral neoplasia * Diseases of the salivary glands * Cysts of the jaws * The odontogenic tumours * Focal bone pathologies of the mandible and maxilla * Diagnostic techniques in oral health practice

Back

The information contained in the 2015 CSU Handbook was accurate at the date of publication: 01 October 2015. The University reserves the right to vary the information at any time without notice.